Moringa leaves decoction in obesity

Phase 2

• Conditions: Health Condition 1: E784- Other hyperlipidemia

• Registration Number: CTRI/2024/01/061866
• Lead Sponsor: Dr Vidya P Gani

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients with dyslipidemia who are not under any medication

Patients from either sex with classical signs and symptoms of medoroga

Patients of age group 20 to 60 years

Patients with BMI equal to or more than 25 kg per meter square Grade 1 and Grade 2 obesity

Total cholesterol above 5.2mmol per L or 200 mg per dL OR Triglycerides above 1.7mmol per L or150mg per dL OR LDL above 3.4 mmol per L or 130MG per Dl OR HDL less than 0.9 mmol per L or 35mg per Dl

Exclusion Criteria

Patients with severe systemic disease or other medical conditions such as hypothyroidism and Cushing s syndrome and hypersensitivity and diabetes etc that preclude participation in this study

Patients with Serum Cholesterol more than 300mg per dl or Serum Triglycerides more than 450mg per dl or Serum HDL less than 20mg per dl or Serum LDL more than 200mg per dl

Patients with life-limiting serious illness

Pregnant and lactating mothers

Cognitive impairment or congenital malformations

Unwilling to participate in research

Study & Design

• Study Type: Interventional
• Study Design: Not specified